Home › Cholesterol › Pennsylvania
Cholesterol clinical trials in Pennsylvania
4 studies for Cholesterol are looking for participants at sites in Pennsylvania.
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- St. Luke's University Health Network, Bethlehem
- Capital Area Research LLC, Camp Hill
- Wellspan Chambersburg Hospital, Chambersburg
- and 3 more
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Newport
- Research Site, Smithfield
RecruitingPhase 3
Ages 18 to 130 · All sexes · Updated Sep 10, 2026 · NCT07619131A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Altoona Center for Clinical Research, Duncansville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Jul 22, 2026 · NCT07477704HoFH, the International Clinical Collaborators Registry
- University of Pennsylvania, Philadelphia
RecruitingObservational study
All ages · All sexes · Updated Dec 18, 2025 · NCT04815005From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.